| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.304 | 20.622 | 23.191 | 29.135 | 37.131 | 22.621 | 26.498 | 26.284 | 31.936 | 40.036 |
| Total Income - EUR | 22.304 | 20.622 | 23.191 | 29.135 | 37.131 | 22.621 | 26.498 | 26.284 | 31.936 | 40.036 |
| Total Expenses - EUR | 14.849 | 12.280 | 12.292 | 16.372 | 25.104 | 17.117 | 16.162 | 24.057 | 29.551 | 38.788 |
| Gross Profit/Loss - EUR | 7.454 | 8.343 | 10.900 | 12.763 | 12.027 | 5.504 | 10.336 | 2.227 | 2.384 | 1.248 |
| Net Profit/Loss - EUR | 6.785 | 7.930 | 10.668 | 12.471 | 11.656 | 5.281 | 10.071 | 1.964 | 2.065 | 46 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Avamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.662 | 24.440 | 23.443 | 22.440 | 21.444 | 21.037 | 19.776 | 19.837 | 18.982 | 18.876 |
| Current Assets | 21.810 | 5.269 | 8.671 | 21.385 | 22.791 | 4.344 | 6.338 | 699 | 2.721 | 3.191 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.512 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 21.810 | 5.269 | 8.671 | 21.385 | 22.791 | 4.344 | 6.338 | 699 | 2.721 | 1.679 |
| Shareholders Funds | 45.801 | 28.769 | 31.154 | 43.054 | 43.358 | 24.629 | 24.947 | 18.877 | 20.884 | 20.814 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 671 | 940 | 960 | 771 | 876 | 753 | 1.167 | 1.659 | 818 | 1.253 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Avamed Srl